1. Lipopolyplex-based delivery system for cancer vaccine delivery
    Jasmeet Kaur et al, 2022, Nanotherapeutics in Cancer Vaccination and Challenges CrossRef
  2. BI-RADS 3-5 microcalcifications: prediction of lymph node metastasis of breast cancer
    Dongzhi Cen et al, 2017, Oncotarget CrossRef

  3. Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers


    Peng Jiang et al, 2020, Cancer Management and Research CrossRef
  4. A Nomogram Model Involving Immunohistochemical Markers for Predicting the Recurrence of Stage I-II Endometrial Cancer
    Peng Jiang et al, 2021, Frontiers in Oncology CrossRef
  5. Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients
    Xingjuan Zhao et al, 2021, Cancer Management and Research CrossRef
  6. Comparison of Proliferation Markers Ki67 and Phosphohistone-H3 (pHH3) in Breast Ductal Carcinoma In Situ
    Dustin E. Bosch et al, 2017, Applied Immunohistochemistry & Molecular Morphology CrossRef
  7. Correlation between contrast-enhanced ultrasound findings and clinicopathological factors in breast cancer
    Masatoshi KADOYA et al, 2017, Choonpa Igaku CrossRef

  8. Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor


    Peng Jiang et al, 2020, OncoTargets and Therapy CrossRef
  9. Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience
    Wang Li et al, 2023, Journal of International Medical Research CrossRef
  10. Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer
    Ning Li et al, 2022, Clinical Medicine Insights: Oncology CrossRef
  11. Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway
    Xiaoyong Fan et al, 2018, Experimental and Therapeutic Medicine CrossRef
  12. Breast Biomarker Immunocytochemistry
    Soheila Korourian et al, 2018, The Breast CrossRef
  13. Nonviral Gene Therapy for Cancer: A Review
    Chiaki Hidai et al, 2018, Diseases CrossRef
  14. Diagnostic ability of real-time quantitative polymerase chain reaction versus immunohistochemistry for Ki-67 assessment in breast cancer: An Indian perspective
    Prerna Chadha et al, 2019, Indian Journal of Medical Research CrossRef
  15. ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis
    Diyu Wang et al, 2017, Tumor Biology CrossRef
  16. Analysis of Factors Related to Lymph Node Metastasis in Early-Stage Type 1 Endometrial Cancer: Verifying the Clinical Value of Positive Threshold of the Immunohistochemical Parameter Ki67
    Peng Jiang et al, 2021, Cancer Management and Research CrossRef
  17. Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity
    Anna Fomitcheva-Khartchenko et al, 2021, PLOS ONE CrossRef
  18. Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of γH2AX, pRPA2, P53, PD-L1 and tumor infiltrating lymphocytes in 76 cases
    S. Voutilainen et al, 2022, BMC Cancer CrossRef
  19. A Winning New Combination? Toward Clinical Application in Oncology
    Quratulain Maqsood et al, 2023, Cancer Control CrossRef
  20. Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer
    Jasmin Zeindler et al, 2019, Breast Cancer Research and Treatment CrossRef
  21. Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
    Yu Meng et al, 2022, Frontiers in Medicine CrossRef
  22. The optimal cut‐off value of immunohistochemical parameter P53 for predicting recurrence of endometrial cancer
    Mingzhu Jia et al, 2021, International Journal of Gynecology & Obstetrics CrossRef
  23. Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
    Xiang Song et al, 2019, PeerJ CrossRef
  24. Прогностическая и предиктивная значимость маркера Ki67 при раке молочной железы
    И. М. Тележникова et al, 2022, Malignant tumours CrossRef